Acute Myeloid Leukemia (AML)
What is acute myeloid leukemia (AML)?
Acute myeloid leukemia (AML) is a type of leukemia. It is also called acute myelogenous leukemia, acute myeloblastic leukemia, acute myelocytic leukemia, acute granulocytic leukemia, and acute nonlymphocytic leukemia.
Leukemia is a cancer of the blood cells that are produced and released into the circulation from the bone marrow. Bone marrow is the soft, inner part of bones where red and white blood cells and platelets are produced. The word "acute" in acute myeloid leukemia refers to the fact that the disease can progress quickly. Symptoms that lead to a diagnosis of AML occur over a relatively short period of time, often days to weeks.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
